|
Q2 FY2026
As of Jun 30, 2026
|
Q1 FY2026
As of Mar 31, 2026
|
Q4 FY2025
As of Dec 31, 2025
|
Q3 FY2025
As of Sep 30, 2025
|
Q2 FY2025
As of Jun 30, 2025
|
Q1 FY2025
As of Mar 31, 2025
|
Q4 FY2024
As of Dec 31, 2024
|
Q3 FY2024
As of Sep 30, 2024
|
Q2 FY2024
As of Jun 30, 2024
|
Q1 FY2024
As of Mar 31, 2024
|
Q4 FY2023
As of Dec 31, 2023
|
Q3 FY2023
As of Sep 30, 2023
|
Q2 FY2023
As of Jun 30, 2023
|
Q1 FY2023
As of Mar 31, 2023
|
Q4 FY2022
As of Dec 31, 2022
|
Q3 FY2022
As of Sep 30, 2022
|
Q2 FY2022
As of Jun 30, 2022
|
Q1 FY2022
As of Mar 31, 2022
|
Q4 FY2021
As of Dec 31, 2021
|
Q3 FY2021
As of Sep 30, 2021
|
|
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Current assets: | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Cash | ||||||||||||||||||||
| Accounts receivable, net of allowance for doubtful accounts of $838 and $835, respectively | ||||||||||||||||||||
| Prepaid expenses and other current assets | ||||||||||||||||||||
| Current assets from discontinued operations | ||||||||||||||||||||
| Investment in Marketable Securities | ||||||||||||||||||||
| Current assets of discontinued operations | ||||||||||||||||||||
| Total current assets | ||||||||||||||||||||
| Property and equipment, net of accumulated depreciation of $61 and $61, respectively | ||||||||||||||||||||
| Intangible assets, net | ||||||||||||||||||||
| Goodwill | ||||||||||||||||||||
| Non-current assets of discontinued operations | ||||||||||||||||||||
| Total assets | ||||||||||||||||||||
| Accounts payable | ||||||||||||||||||||
| Accrued expenses | ||||||||||||||||||||
| Accrued compensation | ||||||||||||||||||||
| Accrued interest | ||||||||||||||||||||
| Contingent consideration for acquisitions | ||||||||||||||||||||
| Deferred payroll taxes | ||||||||||||||||||||
| Stock consideration payable | ||||||||||||||||||||
| Contingent consideration | ||||||||||||||||||||
| Other liabilities | ||||||||||||||||||||
| Loans payable - current portion, net of discount | ||||||||||||||||||||
| Convertible notes payable, net of unamortized discount and costs of $1,205,699 and $0, respectively | ||||||||||||||||||||
| Deferred revenue | ||||||||||||||||||||
| Contract liability | ||||||||||||||||||||
| Line of credit payable | ||||||||||||||||||||
| Refundable deposit on preferred stock purchase | ||||||||||||||||||||
| Derivative liability | ||||||||||||||||||||
| Warrant liability | ||||||||||||||||||||
| Contract liabilities | ||||||||||||||||||||
| Current liabilities of discontinued operations | ||||||||||||||||||||
| Total current liabilities | ||||||||||||||||||||
| Loans payable - long term portion, net of discount | ||||||||||||||||||||
| Total liabilities | ||||||||||||||||||||
| Preferred stock, value | ||||||||||||||||||||
| Series D Preferred Stocks | ||||||||||||||||||||
| Series F Preferred Stocks | ||||||||||||||||||||
| Series D Preferred Stocks | ||||||||||||||||||||
| Series E Preferred Stocks | ||||||||||||||||||||
| Series F Preferred Stocks | ||||||||||||||||||||
| Series D Preferred Shares | ||||||||||||||||||||
| Series F Preferred Shares | ||||||||||||||||||||
| Series D Preferred Stock | ||||||||||||||||||||
| Series E Preferred Stock | ||||||||||||||||||||
| Series F Preferred Stock | ||||||||||||||||||||
| Total preferred stock, value | ||||||||||||||||||||
| Preferred Stocks, Value | ||||||||||||||||||||
| Common stock, $0.0001 par value; 200,000,000 shares authorized; 28,908,839 and 25,946,889 shares issued and outstanding as of June 30, 2026, and December 31, 2025, respectively | ||||||||||||||||||||
| Series D Preferred Stocks | ||||||||||||||||||||
| Total common stock, $0.0001 par value; 200,000,000 shares authorized; 28,908,839 and 25,946,889 shares issued and outstanding as of June 30, 2026, and December 31, 2025, respectively | ||||||||||||||||||||
| Shares to be issued, 0 and 39,196 shares as of September 30, 2023 and December 31, 2022, respectively | ||||||||||||||||||||
| Shares to be issued, 0 and 39,196 shares as of December 31, 2023 and 2022, respectively | ||||||||||||||||||||
| Common Stock to be issued, 506,625 and 0 shares as of December 31, 2024 and 2023, respectively | ||||||||||||||||||||
| Common Stock to be issued, 406,071 and 402,737 shares as of June 30, 2026, and December 31, 2025, respectively | ||||||||||||||||||||
| Additional paid-in capital | ||||||||||||||||||||
| Accumulated deficit | ||||||||||||||||||||
| Total stockholders’ equity | ||||||||||||||||||||
| Noncontrolling interest | ||||||||||||||||||||
| Total liabilities and stockholders’ equity | ||||||||||||||||||||
Loading...